Evidence map›Paper›PMID 39562788›Full record

ArticleNature communications2024

TBK1-associated adapters TANK and AZI2 protect mice against TNF-induced cell death and severe autoinflammatory diseases.

Andrea Ujevic, Daniela Knizkova, Alzbeta Synackova, Michaela Pribikova, Tijana Trivic, Anna Dalinskaya, Ales Drobek, Veronika Niederlova, Darina Paprckova, Roldan De Guia and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Andrea UjevicLaboratory of Immunity & Cell Communication, Division BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic.ORCID 0000-0002-2176-5585
Daniela KnizkovaLaboratory of Immunity & Cell Communication, Division BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic.ORCID 0000-0001-8816-1594
Alzbeta SynackovaLaboratory of Immunity & Cell Communication, Division BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic.ORCID 0000-0002-6854-4405
Michaela PribikovaLaboratory of Immunity & Cell Communication, Division BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic.
Tijana TrivicLaboratory of Immunity & Cell Communication, Division BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic.
Anna DalinskayaLaboratory of Immunity & Cell Communication, Division BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic.
Ales DrobekLaboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.ORCID 0000-0003-1066-9413
Veronika NiederlovaLaboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.ORCID 0000-0001-8768-9039
Darina PaprckovaLaboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
Roldan De GuiaCzech Centre for Phenogenomics and Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic.
Petr KasparekCzech Centre for Phenogenomics and Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic.
Jan ProchazkaCzech Centre for Phenogenomics and Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic.ORCID 0000-0003-4675-8995
Juraj LabajCzech Centre for Phenogenomics and Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic.
Olha FedosieievaCzech Centre for Phenogenomics and Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic.
Bernhard Florian RoeckInstitute for Genetics, CECAD Cluster of Excellence, University of Cologne, Cologne, Germany.ORCID 0009-0002-2306-8481
Ondrej MiholaLaboratory of Germ Cell Development, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
Zdenek TrachtulecLaboratory of Germ Cell Development, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
Radislav SedlacekCzech Centre for Phenogenomics and Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic.ORCID 0000-0002-3352-392X
Ondrej StepanekLaboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.ORCID 0000-0002-2735-3311
Peter DraberLaboratory of Immunity & Cell Communication, Division BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic. peter.draber@unil.ch.ORCID 0000-0001-8658-4614

Funding

Akademie Věd České Republiky (Academy of Sciences of the Czech Republic) RVO 68378050Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 16LW0213Deutsche Forschungsgemeinschaft (German Research Foundation) SFB1403 (414786233)EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 802878EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) Programme EXCELES, LX22NPO5102EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) Programme EXCELES, LX22NPO5103European Molecular Biology Organization (EMBO) 4420Grantová Agentura České Republiky (Grant Agency of the Czech Republic) 21-25251SGrantová Agentura, Univerzita Karlova (Charles University Grant Agency) 406322Grantová Agentura, Univerzita Karlova (Charles University Grant Agency) PRIMUS/20/MED/003Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports) LM2023036Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports) SVV 260637Univerzita Karlova v Praze (Charles University) CooperatioUniverzita Karlova v Praze (Charles University) UNCE/MED/016
6 · The paper itself

Abstract

The cytokine TNF can trigger highly proinflammatory RIPK1-dependent cell death. Here, we show that the two adapter proteins, TANK and AZI2, suppress TNF-induced cell death by regulating the activation of TBK1 kinase. Mice lacking either TANK or AZI2 do not show an overt phenotype. Conversely, animals deficient in both adapters are born in a sub-Mendelian ratio and suffer from severe multi-organ inflammation, excessive antibody production, male sterility, and early mortality, which can be rescued by TNFR1 deficiency and significantly improved by expressing a kinase-dead form of RIPK1. Mechanistically, TANK and AZI2 both recruit TBK1 to the TNF receptor signaling complex, but with distinct kinetics due to interaction with different complex components. While TANK binds directly to the adapter NEMO, AZI2 is recruited later via deubiquitinase A20. In summary, our data show that TANK and AZI2 cooperatively sustain TBK1 activity during different stages of TNF receptor assembly to protect against autoinflammation.

Indexed as

Adaptor Proteins, Signal TransducingMice, KnockoutProtein Serine-Threonine KinasesReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Tumor Necrosis Factor, Type ITumor Necrosis Factor-alphaAnimalsCell DeathEndopeptidasesFemaleHumansInflammationIntracellular Signaling Peptides and ProteinsMaleMiceMice, Inbred C57BLAdaptor Proteins, Signal TransducingEndopeptidasesgumby protein, mouseIntracellular Signaling Peptides and ProteinsNEMO protein, mouseProtein Serine-Threonine KinasesReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Tumor Necrosis Factor, Type IRipk1 protein, mouseTbk1 protein, mouseTnfaip3 protein, mouseTnfrsf1a protein, mouseTnip2 protein, mouseTumor Necrosis Factor-alphaTumor Necrosis Factor alpha-Induced Protein 3

Identifiers

PMID39562788
PMCPMC11576971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.